Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 10, 1997, Pages 783-790

  Richie Jr , John P ^a   Carmella, Steven G ^a,b   Muscat, Joshua E ^a   Scott, Daniella G ^a   Akerkar, Shobha A ^a   Hecht, Stephen S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CARCINOGEN;

ADULT; ARTICLE; CANCER RISK; CAUCASIAN; CLINICAL ARTICLE; DETOXIFICATION; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG CANCER; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SMOKING; TOBACCO; URINALYSIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; CARCINOGENS; COTININE; CREATININE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCURONATES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MENTHOL; MIDDLE AGED; NITROSAMINES; PLANTS, TOXIC; RATS; SMOKING; TOBACCO;

EID: 0030866443     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ries, L. A. G., Miller, B. A., Hankey, B. F., Kosary, C. L., Harras, A., and Edwards, B. K. (eds.). SEER Cancer Statistics Review, 1973-1991; Tables and Graphs. NIH Publ. No. 94-2789, Bethesda, MD: National Cancer Institute, 1994.
2. United States Department of Health and Human Services. Cancer Mortality in the United States: 1950-1977. National Cancer Institute Monograph No. 59. National Cancer Institute, Bethesda, MD, 1982.
3. Baquet, C. R., Horm, J. W., Gibbs, T., and Greenvald, P. Socioeconomic factors and cancer incidence among blacks and whites. J. Natl. Cancer Inst., 83: 551-557, 1991.
4. Novotny, T. E., Warner, K. E., Kendrick, J. S., and Remington, P. L. Smoking by blacks and whites: socioeconomic and demographic differences. Am. J. Public Health, 78: 1187-1189, 1988.
5. Kabat, G. C., Morabia, A., and Wynder, E. L. Comparison of smoking habits of blacks and whites in a case-control study. Am. J. Public Health, 81: 1483-1486, 1991.
6. Hecht, S. S., and Hoffmann, D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis (Lond.), 9: 875-884, 1988.
7. Hecht, S. S. Metabolic activation and detoxification of tobacco-specific nitrosamines: a model for cancer prevention strategies. Drug. Metab. Rev., 26: 373-390, 1994.
8. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res., 50: 3772-3780, 1990.
9. Hecht, S. S., Trushin, N., Castonguay, A., and Rivenson, A. Comparative tumorigenicity and DNA methylation in F-344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res., 46: 498-502, 1986.
10. Hecht, S. S., Spratt, T. E., and Trushin, N. Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F-344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonomicotine. Carcinogenesis (Lond.), 9: 161-165, 1988.
11. 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. Carcinogenesis (Lond.), 14: 151-154, 1993.
12. Foiles, P. G., Akerkar, S. A., Carmella, S. G., Kagan, M., Stoner, G. D., Resau, J. H., and Hecht, S. S. Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem. Res. Toxicol., 4: 364-368, 1991.
13. Belinski, S. A., Devereux, T. R., Maronpot, R. R., Stoner, G. D., and Anderson, M. W. The relationship between the formation of promutagenic adducts and the activation of the K-ras proto-oncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res., 49: 5305-5311, 1989.
14. Ronai, Z., Gradia, S., Peterson, L. A., and Hecht, S. S. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-puridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis (Lond.), 14: 2419-2422, 1993.
15. Hecht, S. S., Trushin, N., Reid-Quinn, C. A., Burak, E. S., Jones, A. B., Southers, J. L., Gombar, C. T., Carmella, S. G., Anderson, L. M., and Rice, J. M. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacoktnetics and characterization of glucuronide metabolites. Carcinogenesis (Lond.), 14: 229-236, 1993.
16. Morse, M. A., Eklind, K. I., Toussaint, M., Amin, S. G., and Chung, F-L. Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis (Lond.), 11: 1819-1823, 1990.
17. Carmella, S. G., Akerkar, S. A., and Hecht, S. S. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res., 53: 721-724, 1993.